Literature DB >> 20532702

Use of medications to lower urine protein level in patients with diabetic kidney disease.

Robert C Stanton1.   

Abstract

Entities:  

Year:  2010        PMID： 20532702     DOI： 10.1007/s11892-010-0125-3

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


× No keyword cloud information.
  20 in total

1.  How to achieve renal protection in the light of ONTARGET?

Authors:  Christos Chatzikyrkou; Jan Menne; Hermann Haller
Journal:  J Hypertens Suppl       Date:  2009-06

2.  Importance of glucose-6-phosphate dehydrogenase activity for cell growth.

Authors:  W N Tian; L D Braunstein; J Pang; K M Stuhlmeier; Q C Xi; X Tian; R C Stanton
Journal:  J Biol Chem       Date:  1998-04-24       Impact factor: 5.157

3.  Quantitation of proteinuria by the use of protein-to-creatinine ratios in single urine samples.

Authors:  S J Schwab; R L Christensen; K Dougherty; S Klahr
Journal:  Arch Intern Med       Date:  1987-05

4.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

5.  Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension.

Authors:  J Blacher; G Amah; X Girerd; A Kheder; H Ben Mais; G M London; M E Safar
Journal:  Am J Hypertens       Date:  1997-12       Impact factor: 2.689

6.  Importance of glucose-6-phosphate dehydrogenase activity in cell death.

Authors:  W N Tian; L D Braunstein; K Apse; J Pang; M Rose; X Tian; R C Stanton
Journal:  Am J Physiol       Date:  1999-05

7.  High glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells.

Authors:  Z Zhang; K Apse; J Pang; R C Stanton
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

Review 8.  Dual blockade of the renin-angiotensin-aldosterone system in cardiac and renal disease.

Authors:  Maartje C J Slagman; Gerjan Navis; Gozewijn D Laverman
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-03       Impact factor: 2.894

9.  Aliskiren combined with losartan in type 2 diabetes and nephropathy.

Authors:  Hans-Henrik Parving; Frederik Persson; Julia B Lewis; Edmund J Lewis; Norman K Hollenberg
Journal:  N Engl J Med       Date:  2008-06-05       Impact factor: 91.245

Review 10.  The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis.

Authors:  Brendan B McCormick; Amy Sydor; Ayub Akbari; Dean Fergusson; Steve Doucette; Greg Knoll
Journal:  Am J Kidney Dis       Date:  2008-04-22       Impact factor: 8.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.